Fig. 3: Baseline prevalence of selected structural biomarkers. | Eye

Fig. 3: Baseline prevalence of selected structural biomarkers.

From: Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study

Fig. 3

The prevalence of reticular pseudodrusen (A), pigmentary abnormalities (B), hyperreflective foci (C) and incomplete or complete retinal pigment epithelium and outer retinal atrophy (D) noticeably varied ross MACUSTAR study sites in all participants with intermediate age-related macular degeneration.

Back to article page